GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Allied ALID · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2024

Revenue

$96,180

FY2015FY2024

Net income

−$4.0m

FY2015FY2024

Free cash flow

−$2.0m

FY2015FY2024

Shareholders' equity

−$7.5m

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue$96,180$72,096$165,596$12,518————$9,000—
Gross profit−$323,132−$1.5m$74,120−$625,474−$90,537———$9,000—
Research and development——$12,062——$35,337————
Operating income−$2.8m−$10.3m−$14.3m−$7.6m−$3.5m−$23,108−$19,253−$20,251−$2,063−$10,000
Net income−$4.0m−$10.7m−$16.8m−$12.2m−$6.8m−$23,108−$19,253−$20,251−$2,063−$10,000
Diluted earnings per share-0.03-0.11-0.17-0.14-0.08-0.00-0.00-0.00-0.00—

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assets$2.1m$2.1m$5.8m$4.6m$7.1m$103$756$151$7,159$10,000
Cash and short-term investments—$209,736$96,043$419,825$94,047$103$756——$10,000
Total liabilities$9.7m$8.9m$7.1m$5.6m$3.4m$59,902$37,447$17,589$4,346—
Debt—$5.9m$5.1m$3.7m$2.0m—————
Shareholders' equity−$7.5m−$6.9m−$1.3m−$970,781$3.7m−$59,799−$36,691−$17,438$2,813—
Shares outstanding115m97m96m89m85m83m87m87m13m74m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations−$2.0m−$2.0m−$4.3m−$4.0m−$3.2m−$12,636−$21,053−$14,099−$4,498−$10,000
Capital spending−$9,892−$87,795−$1.2m−$223,854−$111,553−$2.0m−$2.0m———
Free cash flow−$2.0m−$2.0m−$5.5m−$4.2m−$3.3m−$2.0m−$2.0m−$14,099−$4,498−$10,000

Latest quarters

By quarter end

Nov 2024Aug 2024May 2024Feb 2024Nov 2023Aug 2023May 2023Feb 2023
Revenue$27,669—$77,141—$2,471$2,471——
Gross profit$13,611−$395,645$55,477—−$1.5m−$1.5m−$39,643−$36,898
Operating income−$514,704−$789,351−$709,884−$666,324−$2.3m−$2.3m−$2.2m−$2.0m
Net income−$780,290−$1.4m−$891,423−$865,826−$5.1m−$5.1m−$2.2m−$2.1m
Diluted earnings per share-0.01-0.01-0.01-0.01-0.05-0.05-0.02-0.02
Cash from operations———————−$1.0m
Total assets$2.0m$2.1m$2.2m$2.3m$2.1m$2.1m$6.2m$6.1m
Cash and short-term investments————$209,736—$3,516$164,940
Debt————$5.8m—$5.7m$5.5m
Shareholders' equity−$7.6m−$7.5m−$7.7m−$7.5m−$6.9m−$6.9m−$2.4m−$2.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue97.3%——
Operating income-28.0%161.7%75.9%
Net income-31.1%180.0%81.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin-1060.7%-674.5%——
Operating margin-7786.1%-10107.4%——
Net margin-8707.0%-12582.4%——

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings-0.1-0.0—-0.0-0.0-3.6
Price to sales2.21.50.422.0——

Share price return

Finished calendar years

2025202420232022202120202019
Return-79%90%69%-76%116%49%100%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 6.666-for-1 split · 7 Aug 2019

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.